Menu
We bring you the latest updates with unbiased and factual coverage on psychedelics—including legislation, research, investments, business news, and pharmaceutical trials.
Check out the reMind newsletters, video series, and industry interviews.
We host conferences and trade shows, webinars and a speaker series for entrepreneurs and individuals looking to drive innovation, legislation, conversation and commerce in psychedelics.
Missed the Psychedelics Business Forum? Join our community to access sessions on-demand.
reMind publishes special reports on innovation, social impact, trends, legislative actions, research and more. We are committed to moving the market and advancing the business of break-through medicine ethically.
Get our latest report: The reMind 2023 Industry Primer
Want to rewatch your favorite sessions from the Psychedelics Business Forum?
Weren’t able to attend?
Now you can watch all the sessions.
At this exclusive one-day Psychedelics Business Forum, you will hear from experts in Psychedelics covering a variety of topics including:
– The current state of PsychedelicsAt this exclusive one-day event you will hear from experts covering a variety of topics including:
– The current state of Psychedelics
– Investment trends
– Commercialization timelines
– Indigenous inclusion
– Conservation and much more
***Passes starting at $349
Join us for our debut event alongside MJBizCon®, one of the largest cannabis industry conferences in the world, which attracts a large crossover audience of professionals interested in the latest developments in the psychedelics industry.
The Psychedelics Business Forum featured over two dozen expert leaders meeting to discuss, share and shape the future of the psychedelics industry
Host
Psychoactive podcast
Managing Partner
JLS Fund
Strategic Initiatives Officer - MAPS
Program Manager
Indigenous Medicine Conservation Fund
– Key information for those entering the psychedelics industry
– 11 trends that will shape the marketplace in 2023
– Origins to innovation to tensions; where the business of psychedelics is today
